Treatment of menstrual migraine

F. Granella, G. Sances, G. Messa, M. De Marinis, G. C. Manzoni

Research output: Contribution to journalArticlepeer-review

Abstract

Because of its pathophysiological and clinical peculiarities, true menstrual migraine (MM) (i.e. migraine starting exclusively between the days immediately before and immediately after the first day of the menstrual cycle) requires an ad hoc management different from that of other migraines. The paucity of well-conducted, controlled clinical trials and the lack of a universally accepted definition of MM have meant that the treatment of MM is still largely empirical. In our clinical practice, we adopt a sequential therapeutic approach, including the following steps: (i) acute attack drugs (sumatriptan, ergot derivatives, NSAIDs); (ii) intermittent prophylaxis with ergot derivatives or NSAIDs; (iii) oestrogen supplementation with percutaneous or transdermal oestradiol (100 μg patches); (iv) antioestrogen agents (danazol, tamoxifen).

Original languageEnglish
Pages (from-to)35-38
Number of pages4
JournalCephalalgia, Supplement
Volume17
Issue number20
Publication statusPublished - 1997

Keywords

  • Acute attack treatment
  • Menstrual migraine
  • Prophylactic treatment

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Treatment of menstrual migraine'. Together they form a unique fingerprint.

Cite this